companydata.dkcompanydata.dk

EUROPHARMA.DK ApS: Financial statements 2016

CVR: 34601933

Source: annual report 2016, Danish Business Authority

01/01/201631/12/2016

EUROPHARMA.DK ApS (CVR 34601933) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 29,260,677 and a net result of DKK 6,540,655 compared with DKK 311,702 the year before. That is an increase of 86.7% compared with the year before. Equity in the 2016 report amounted to DKK 80,610,926. The solvency ratio was 42%. The company had 40 employees in the financial year.

Gross Profit
DKK 29,260,677
Profit/Loss
DKK 6,540,655
Equity
DKK 80,610,926
Total Assets
DKK 191,712,762
Employees
40

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2016-29.3 mio.6.5 mio.80.6 mio.40
2015-15.7 mio.312 t.74.1 mio.32
2014-14.6 mio.2.8 mio.11.4 mio.30
2013--294 t.-12.5 mio.-11.6 mio.-
2012-14.6 mio.-49 t.951 t.29

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like EUROPHARMA.DK ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2016

EUROPHARMA.DK ApS: The 2015 annual report is outJun 6, 2016

EUROPHARMA.DK ApS has published its annual report for 2015. Gross profit came to DKK 15,668,660, and the net result was DKK 311,702.

About EUROPHARMA.DK ApS

EUROPHARMA.DK ApS was a Danish company of the type Anpartsselskab based in Esbjerg N, founded in 2012. The company has been dissolved. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named EUROPHARMA.DK 2012 ApS and EUROPHARMA.DK 2012 ApS UNDER STIFTELSE. The company has 0 employees (2018). In 2016, the company reported a gross profit of DKK 29,260,677 and a net result of DKK 6,540,655 compared with DKK 311,702 the year before. Equity in the 2016 report amounted to DKK 80,610,926.

Source: annual report 2016, Danish Business Authority

Other financial years